Mapping to guide ablation for ventricular tachycardia
Part of Heart & circulation clinical trials.
This study tests a new way to map the heart's electrical activity to guide a procedure that destroys the tissue causing fast, dangerous heart rhythms. It's for people with heart disease and ventricular tachycardia that hasn't been controlled by medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a sustained episode of ventricular tachycardia (lasting more than 30 seconds) in the last 6 months.
- You have tried at least one heart rhythm medication that didn't work or caused side effects.
- You have structural heart disease (like a prior heart attack or cardiomyopathy) with scarring on your heart muscle.
- You do not have an active infection, recent heart surgery, or other serious conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This trial tests two different ways of mapping the heart to guide treatment for a dangerous fast heart rhythm. The goal is to see which mapping method works better for people with an ICD who need a procedure called ablation to stop the rhythm.
This study tests a new way of mapping damaged heart muscle to improve the precision of a procedure called catheter ablation, which treats dangerously fast heart rhythms. It may help people with heart disease who need this procedure.
This trial tests a more detailed way to map the heart during an ablation procedure for ventricular tachycardia (a fast, abnormal heartbeat). It uses special catheters to find the exact spots causing the problem, which may help make the ablation safer and more effective.
This trial tests a special catheter to map abnormal heart rhythms like ventricular tachycardia or atrial fibrillation. It may help patients who need a procedure to find and treat the source of these fast or irregular heartbeats.
Hear when a new Sustained Monomorphic VT (MMVT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.